UK markets closed
NIKKEI 225
38,460.08 +907.92 (+2.42%) HANG SENG
17,201.27 +372.34 (+2.21%) CRUDE OIL
82.84 -0.52 (-0.62%) GOLD FUTURES
2,328.90 -13.20 (-0.56%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,416.98 -1,806.49 (-3.39%)
Accelerate Diagnostics, Inc. (AXDX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 0.9500 |
| Open | 0.9215 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.8721 - 0.9499 |
| 52-week range | 0.7300 - 11.9000 |
| Volume | |
| Avg. volume | 79,961 |
| Market cap | 20.17M |
| Beta (5Y monthly) | 0.53 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.9400 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.50 |
Insider MonkeyAccelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2023 Earnings Call Transcript
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2023 Earnings Call Transcript March 28, 2024 Accelerate Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.89 EPS, expectations were $-0.62. Accelerate Diagnostics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and […]
- Thomson Reuters StreetEvents
Q4 2023 Accelerate Diagnostics Inc Earnings Call
Q4 2023 Accelerate Diagnostics Inc Earnings Call
ZacksAccelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue Estimates
Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of -43.55% and 20.34%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.